IGIV-C

· Grifols Therapeutics LLC

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for IGIV-C, covering 2019-03-05 to 2020-04-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Efficacy and Safety of IGIV-C in Patients With Myasthenia Gravis Exacerbations [Phase 3]